We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microchip Demonstrates Biomolecules’ Magnetic Attraction

By LabMedica International staff writers
Posted on 02 Nov 2011
Scientists have developed a low-power microchip that uses a combination of magnetic switches and microfluidics to trap and transport magnetic beads. More...
The innovative transport chip may have applications in biotechnology and medical diagnostics.

A major advance in the new chip is the use of magnetic switches similar to those in a computer random access memory. As described in an article published October 3, 2011, in the journal Applied Physics Letters, the investigators, from the US National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) and University of Colorado Boulder (CU; USA), used the chip to trap, release, and transport magnetic beads that potentially could be used as transport vehicles for biomolecules such as DNA.

Traditional microfluidics systems use pumps and valves to move particles and liquids through channels. Magnetic particle transport microchips provide a new application for microfluidics, but typically require continuous power, and in some instances, cooling to avoid sample damage from excessive heating. The technology eliminates these drawbacks while offering the possibility for random access two-dimensional control and a memory that lasts even with the power off.

The demo chip features two adjacent lines of 12 thin-film magnet switches called spin valves, usually used as magnetic sensors in read heads of high-density computer disk drives. In this case, however, the spin valves have been optimized for magnetic trapping. Pulses of electric current are used to switch individual spin valve magnets “on” to trap a bead, or “off” to release it, and thereby move the bead down a ladder formed by the two lines. The beads begin suspended in salt water above the valves before being trapped in the array.

“It’s a whole new way of thinking about microfluidics,” said NIST physicist Dr. John Moreland. “The cool thing is it’s a switchable permanent magnet--after it’s turned on it requires no power. You beat heat by switching things quickly, so you only need power for less than a microsecond.”

NIST researchers previously shown that spin valves could be used to trap and rotate particles and recently were awarded two patents related to the idea of a magnetic chip.

Magnetic tags are utilized in bioassays such as protein and DNA purification and cell breakdown and separation. The chip demonstration provides a conceptual foundation for a more complex magnetic random access memory (MRAM) for molecular and cellular manipulation. For example, programmable microfluidic MRAM chips might simultaneously regulate a large number of beads, and the attached molecules or cells, to assemble “smart” tags with specified characteristics, such as an affinity for a given protein at a specific position in the array.

NIST is also interested in developing cellular and molecular tags for magnetic resonance imaging (MRI) research in which individual cells, such as stem cells or cancer cells, would be tagged with a smart magnetic biomarker that can be monitored remotely in an MRI scanner, according to Dr. Moreland. Automated spin valve chips might also be used in portable instruments for rapid medical diagnosis or DNA sequencing.

Related Links:

The US National Institute of Standards and Technology
University of Colorado Boulder
Video NIST CU Magnetic Microfluidic Chip





New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.